ライフサイエンスコーパス: vasoactive substance

1 lar function include more than production of vasoactive substances.

2 othelial cells targeted by mast cell-derived vasoactive substances.

3 rum and tissue ACE activity as well as other vasoactive substances.

4 alyzed by the cytochrome P450 system and are vasoactive substances.

5 activating mast cells, which in turn release vasoactive substances.

6 nd alter the metabolism of a number of other vasoactive substances.

7 ssible by the ability of RBCs to release the vasoactive substance adenosine triphosphate (ATP) in res

8 astrocytic activation, stimulates release of vasoactive substances and dilation of cerebral vasculatu

9 estration allowing for passage of diffusible vasoactive substances and interface of endothelial cell

10 activation of G protein-coupled receptors by vasoactive substances and neurotransmitters.

11 For the local delivery of potentially vasoactive substances and simultaneous measurement of AT

12 he general measures, ventilation strategies, vasoactive substances, and surgical as well as mechanica

13 It has been proposed that release of vasoactive substances by astrocytes couples neuronal act

14 xocytosis of Weibel-Palade bodies, releasing vasoactive substances capable of causing vascular thromb

15 xocytosis of Weibel-Palade bodies, releasing vasoactive substances capable of causing vascular thromb

16 tions examined the endothelial production of vasoactive substances during heterologous serum exposure

17 of inflammatory mediators such as cytokines, vasoactive substances, free radicals, and chemokines, wh

18 odilatation is a consequence of release of a vasoactive substance from the endothelium owing to mecha

19 from nerve terminals and histamine and other vasoactive substances from granulocytes may be responsib

20 of autophagy in the paracrine regulation of vasoactive substances from the endothelium.

21 Plasma levels of endothelin 1, a potent vasoactive substance implicated in pulmonary hypertensio

22 8 days after 6-OHDA) on the distribution of vasoactive substances in ECs of the rat thoracic aorta.

23 ional changes are associated with changes in vasoactive substances in ECs.

24 e for quantitative studies of the content of vasoactive substances in ECs.

25 is a dynamic tissue, secreting and modifying vasoactive substances, influencing the behavior of other

26 By releasing vasoactive substances into the circulation, carcinoid tu

27 Bradykinin (BK), an endogenous vasoactive substance, is released from ischemic myocardi

28 and then assaying the conditioned media for vasoactive substances on isolated aortic rings and small

29 On stimulation by a vasoactive substance or shear stress, PECAM-1 became tyr

30 Antibodies linked to vasoactive substances or conjugated to liposomes increas

31 (K(ATP)) channel is targeted by a variety of vasoactive substances, playing an important role in vasc

32 latation also occurs during hypoxia, and the vasoactive substance(s) responsible for skeletal muscle

33 B breakdown after intravitreous injection of vasoactive substances shows that agents can be grouped b

34 egulated by the antagonistic balance between vasoactive substances such as NO and angiotensin II (Ang

35 lude that while astrocytes can still release vasoactive substances, vascular amyloid deposits render